Lower cost strategies for triage of human papillomavirus DNA-positive women.
about
Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choicesEffectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china.p16 Immunohistochemistry Interpretation by Nonpathologists as an Accurate Method for Diagnosing Cervical Precancer and Cancer.Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda.Cancer control programs in East Asia: evidence from the international literaturePast and future of prophylactic ablation of the cervical squamocolumnar junctionFeasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening.Resources Required for Cervical Cancer Prevention in Low- and Middle-Income CountriesA Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan AfricaTriage of HPV positive women in cervical cancer screening.p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China.Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana.Implementation of cervical cancer screening and prevention in China--challenges and reality.Prophylactic HPV vaccination: past, present, and future.Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.Vaginal self-sampling as a diagnosis tool in low-income countries and potential applications for exploring the infectious causes of miscarriage.Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings.Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.Triage of high-risk HPV positive women in cervical cancer screening.Management of high-risk HPV-positive women for detection of cervical (pre)cancer.Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas?High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting.Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.Stability, integrity, and recovery rate of cellular nucleic acids preserved in a new liquid-based cytology medium.HPV E6 oncoproteins and nucleic acids in neck lymph node fine needle aspirates and oral samples from patients with oropharyngeal squamous cell carcinoma.Advancing rapid point-of-care viral diagnostics to a clinical settingProtocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda
P2860
Q26775085-FA4649DE-E8C2-41DE-B277-0530C775B420Q30278596-7C14DC43-AF3E-44FB-92C2-21BA720283F7Q30352388-3F893282-6DF3-4BB4-9A26-308EDAA99327Q30388952-C6C2A3F1-A6C1-4D49-83D7-B341A98F64A3Q34170451-8B25F422-7903-41C9-BE45-AF3E24F1D586Q35605616-DFECF9DC-ACF4-4865-8229-1AE5DAEBA815Q35832553-B3D391C9-1E60-4D60-A7C5-30C3A6E4D570Q36154922-FCBD0517-ED31-468C-8E95-B1A8168592BDQ36169189-2EAF83AB-5977-4129-85CA-19811635F8E5Q36405019-0060EB64-E072-46B6-949F-6EDF4C54EA71Q36679896-7F721FC2-7D0C-438F-9EE6-F82C2A678812Q37662140-1E3F982F-2E15-4C32-87BD-016EF1DAF343Q37679237-AF2BED16-F857-4595-BA36-292A663A612AQ38268335-EE836DE7-0853-43F2-8CBE-82E3909B339BQ38597567-F388E1B9-C4CD-4684-8424-9F3390C1ED5DQ38660469-C9389709-6A40-48D1-9982-ACFBE0623D73Q38672124-5C4F0457-374E-4387-A858-21988031426AQ38679549-99D88770-D8E8-4AEB-A6BA-A47B87C1EF57Q38723374-4072FA21-8671-401F-948C-76265EDC8C81Q38824019-BF7EA5CF-5EA8-459A-B6D4-FA8FEA47994FQ38837737-96F32E37-1B64-49B2-A8FB-906CE2E67C88Q40129828-A4F8CA63-2D83-4145-B5BD-5D2F3C182D69Q40476346-A2FA5601-0FFD-4EA5-AFC2-A650E9671105Q40717962-7F46488A-759C-405B-AF77-EC2F2D68A8D8Q41130336-29627C21-8036-42B7-B2DF-DD131DA6233BQ41670583-AC50069A-774A-4DE4-8925-C0CAC26B95FDQ42184589-65921675-E9D8-4935-9ECC-F343D50F4260Q43924111-BD157A38-7E33-4725-82FD-24194D14F375Q48227578-30E91951-26BA-4165-9E6F-EFE938A98A5CQ55333361-2EE5A36E-3789-4436-8916-BF65710847C7Q56766086-3F367406-3620-4B2F-B4CD-E6EBD184A1F6Q58800228-78C5583D-B067-43D5-A0F2-786D7299AF20
P2860
Lower cost strategies for triage of human papillomavirus DNA-positive women.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Lower cost strategies for triage of human papillomavirus DNA-positive women.
@ast
Lower cost strategies for triage of human papillomavirus DNA-positive women.
@en
Lower cost strategies for triage of human papillomavirus DNA-positive women.
@nl
type
label
Lower cost strategies for triage of human papillomavirus DNA-positive women.
@ast
Lower cost strategies for triage of human papillomavirus DNA-positive women.
@en
Lower cost strategies for triage of human papillomavirus DNA-positive women.
@nl
prefLabel
Lower cost strategies for triage of human papillomavirus DNA-positive women.
@ast
Lower cost strategies for triage of human papillomavirus DNA-positive women.
@en
Lower cost strategies for triage of human papillomavirus DNA-positive women.
@nl
P2093
P2860
P356
P1476
Lower cost strategies for triage of human papillomavirus DNA-positive women.
@en
P2093
Charles Mahoney
Fang-Hui Zhao
Johannes Schweizer
Jose Jeronimo
Le-Ni Kang
Mark H Stoler
Marthe Berard-Bergery
Melissa Valdez
P2860
P304
P356
10.1002/IJC.28616
P577
2013-12-03T00:00:00Z